Plasma Vasopressin Levels in Patients With Right-Sided Heart Dysfunction and Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

ObjectivesPatients with left-sided heart dysfunction and volume overload often have associated elevations in vasopressin from neuroendocrine activation. The authors investigated perioperative levels of vasopressin in patients with isolated right-sided heart dysfunction from chronic thromboembolic pulmonary hypertension.DesignProspective, observational study.SettingSingle center, tertiary hospital.ParticipantsPatients with chronic thromboembolic pulmonary hypertension undergoing pulmonary thromboendarterectomy.InterventionsVasopressin levels were measured in 22 patients during the perioperative period.Measurements and Main ResultsVasopressin was undetectable in 8/22 patients at baseline. As a group, vasopressin levels at baseline and after induction of anesthesia were 0.8 pg/mL (median; 0.5-1.5, interquartile range of 25% and 75%) and 0.7 pg/mL (median; 0.5-1.4, interquartile range of 25% and 75%), respectively. During cardiopulmonary bypass (CPB), vasopressin increased to 13.9 pg/mL (median; 6.7-19.9, interquartile range of 25% and 75%). Vasopressin remained elevated after deep hypothermic circulatory arrest (DHCA) at 10.5 pg/mL (median; 6.5-19.9 interquartile range of 25% and 75%) and after CPB at 19.9 pg/mL (median; 11.1-19.9 interquartile range of 25% and 75%).ConclusionsVasopressin levels in PTE patients are in the low-to-normal range at baseline and may be a clinically relevant issue in the hemodynamic management of PTE.